116 related articles for article (PubMed ID: 30998140)
1. [Expression and Clinical Significance of PD-L1 and MicroRNA-138-5p in Patients with Acute Myeloid Leukemia].
Huang CY; Zha XF; Wen WR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):373-378. PubMed ID: 30998140
[TBL] [Abstract][Full Text] [Related]
2. MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs.
Pyzer AR; Stroopinsky D; Rosenblatt J; Anastasiadou E; Rajabi H; Washington A; Tagde A; Chu JH; Coll M; Jiao AL; Tsai LT; Tenen DE; Cole L; Palmer K; Ephraim A; Leaf RK; Nahas M; Apel A; Bar-Natan M; Jain S; McMasters M; Mendez L; Arnason J; Raby BA; Slack F; Kufe D; Avigan D
Leukemia; 2017 Dec; 31(12):2780-2790. PubMed ID: 28555079
[TBL] [Abstract][Full Text] [Related]
3. [Relationship of PD-L1 Expression with the Clinical Features and Prognosis of Patients with Primary Acute Leukemia].
Ma H; Li N
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1034-8. PubMed ID: 27531770
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow mesenchymal stromal cells attenuate liver allograft rejection may via upregulation PD-L1 expression through downregulation of miR-17-5p.
Chen Q; Zhou R; Zhang Y; Zhu S; Xiao C; Gong J; Li K; Tang H; Sun C; Zhang J
Transpl Immunol; 2018 Dec; 51():21-29. PubMed ID: 30092337
[TBL] [Abstract][Full Text] [Related]
5. [Expression and Significance of PD-L1, HSP90 and HSP90α in Serum of Patients with Acute Leukemia].
Ma XJ; Zhang FH; Sun L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1384-1389. PubMed ID: 29070112
[TBL] [Abstract][Full Text] [Related]
6. [Expression of miR-155 in Acute Myeloid Leukemia and Its Clinical Significance].
Hu XL; Tang AP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):980-4. PubMed ID: 27531760
[TBL] [Abstract][Full Text] [Related]
7. A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in relapsed/refractory acute myeloid leukemia.
Saxena K; Herbrich SM; Pemmaraju N; Kadia TM; DiNardo CD; Borthakur G; Pierce SA; Jabbour E; Wang SA; Bueso-Ramos C; Loghavi S; Tang G; Cheung CM; Alexander L; Kornblau S; Andreeff M; Garcia-Manero G; Ravandi F; Konopleva MY; Daver N
Cancer; 2021 Oct; 127(20):3761-3771. PubMed ID: 34171128
[TBL] [Abstract][Full Text] [Related]
8. Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia.
Wang Q; Feng T; Xu J; Miao MH; Ji XQ; Zhu H; Shao XJ
J Cell Physiol; 2019 Apr; 234(4):4200-4205. PubMed ID: 30171606
[TBL] [Abstract][Full Text] [Related]
9. [Expression of TFPI-2 gene and its promoter methylation in acute myeloid leukemia].
Shao LL; Fan J; Wang R; Feng LL; Zhen CQ; Sui XH; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):920-6. PubMed ID: 25130804
[TBL] [Abstract][Full Text] [Related]
10. Expression of PD-L1 on regulatory B cells in patients with acute myeloid leukaemia and its effect on prognosis.
Shi Y; Liu Z; Wang H
J Cell Mol Med; 2022 Jun; 26(12):3506-3512. PubMed ID: 35610758
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of miR-34a in Bone Marrow Mononuclear Cells of Acute Myeloid Leukemia Patients.
Liu X; Li H
Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162890
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of PD-L1 predicts poor prognosis and is associated with miR-191-5p dysregulation in colon adenocarcinoma.
Chen XY; Zhang J; Hou LD; Zhang R; Chen W; Fan HN; Huang YX; Liu H; Zhu JS
Int J Immunopathol Pharmacol; 2018; 32():2058738418790318. PubMed ID: 30045644
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and clinical correlation of TIM-3 and PD-1/PD-L1 expressions in leukemic cells and tumor microenvironment in newly diagnosed acute myeloid leukemia.
Chajuwan T; Kansuwan P; Kobbuaklee S; Chanswangphuwana C
Leuk Lymphoma; 2022 Feb; 63(2):450-456. PubMed ID: 34585994
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of immune checkpoints in acute myeloid leukemia.
Chen C; Liang C; Wang S; Chio CL; Zhang Y; Zeng C; Chen S; Wang C; Li Y
J Hematol Oncol; 2020 Apr; 13(1):28. PubMed ID: 32245463
[TBL] [Abstract][Full Text] [Related]
15. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
16. miR-142-5p regulates CD4+ T cells in human non-small cell lung cancer through PD-L1 expression via the PTEN pathway.
Wan J; Ling X; Peng B; Ding G
Oncol Rep; 2018 Jul; 40(1):272-282. PubMed ID: 29767245
[TBL] [Abstract][Full Text] [Related]
17. [Detection of WT1 gene in acute myeloid leukemia children by real-time fluorescent quantitative RT-PCR and its clinical significance].
Zhang R; Sun HQ; Li G; Bai FY; Yang Y; Jing Q; Shi YJ; Yang JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):959-63. PubMed ID: 21867623
[TBL] [Abstract][Full Text] [Related]
18. Programmed Death Ligand-1 is Frequently Expressed in Primary Acute Myeloid Leukemia and B-Acute Lymphoblastic Leukemia.
Hamdan SO; Sughayer M; Khader M; Tbakhi A; Khudirat S; Hejazi A; AlRyalat S; Bustami N; Aladily TN
Clin Lab; 2022 Apr; 68(4):. PubMed ID: 35443604
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia.
Wang X; Li J; Dong K; Lin F; Long M; Ouyang Y; Wei J; Chen X; Weng Y; He T; Zhang H
Cell Signal; 2015 Mar; 27(3):443-52. PubMed ID: 25499621
[TBL] [Abstract][Full Text] [Related]
20. Serum level of miR-10-5p as a prognostic biomarker for acute myeloid leukemia.
Zhi Y; Xie X; Wang R; Wang B; Gu W; Ling Y; Dong W; Zhi F; Liu Y
Int J Hematol; 2015 Sep; 102(3):296-303. PubMed ID: 26134365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
